ArticlePloS one2014

Geminin overexpression promotes imatinib sensitive breast cancer: a novel treatment approach for aggressive breast cancers, including a subset of triple negative.

Zannel Blanchard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.